share_log

HC Wainwright & Co. Initiates Coverage On Biohaven With Buy Rating, Announces Price Target of $50

HC Wainwright & Co. Initiates Coverage On Biohaven With Buy Rating, Announces Price Target of $50

HC Wainwright & Co.以买入评级启动对Biohaven的报道,宣布目标股价为50美元
Benzinga ·  2023/12/22 06:12

HC Wainwright & Co. analyst Douglas Tsao initiates coverage on Biohaven (NYSE:BHVN) with a Buy rating and announces Price Target of $50.

HC Wainwright & Co. 分析师曹道格拉斯以买入评级开始对Biohaven(纽约证券交易所代码:BHVN)进行报道,并宣布目标股价为50美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发